ResMed Net Long-Term Debt 2010-2025 | RMD

ResMed net long-term debt for the twelve months ending March 31, 2025 was $-0.830B, a 1409.09% increase year-over-year.

  • ResMed annual net long-term debt for 2024 was $-0.73B, a 209.77% decline from 2023.
  • ResMed annual net long-term debt for 2023 was $0.665B, a 445.08% increase from 2022.
  • ResMed annual net long-term debt for 2022 was $0.122B, a 123.37% decline from 2021.

ResMed Net Long-Term Debt 2010-2025 | RMD

  • ResMed annual net long-term debt for 2024 was $-0.73B, a 209.77% decline from 2023.
  • ResMed annual net long-term debt for 2023 was $0.665B, a 445.08% increase from 2022.
  • ResMed annual net long-term debt for 2022 was $0.122B, a 123.37% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$229.7B
Boston Scientific (BSX)$154.4B
Stryker (SYK)$149.4B
EssilorLuxottica (ESLOY)$132.1B
Medtronic (MDT)$115.1B
Lonza Group Ag (LZAGY)$49.6B
Haleon (HLN)$44.5B
Agilent Technologies (A)$34.1B
GE HealthCare Technologies (GEHC)$34.1B
Terumo (TRUMY)$24.5B
Koninklijke Philips (PHG)$23.1B
Insulet (PODD)$20.6B
Zimmer Biomet Holdings (ZBH)$18.6B
Baxter (BAX)$14.6B
Smith & Nephew SNATS (SNN)$13.2B
Demant (WILYY)$8.6B
Sunny Optical Technology (SNPTF)$8.6B
Bio-Rad Laboratories (BIO)$6.8B
Lantheus Holdings (LNTH)$5.7B
Prestige Consumer Healthcare (PBH)$3.8B
Perrigo (PRGO)$3.8B
Haemonetics (HAE)$3.7B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
ICU Medical (ICUI)$3.2B
QuidelOrtho (QDEL)$2B
LeMaitre Vascular (LMAT)$1.9B
AtriCure (ATRC)$1.5B
Acuren (TIC)$1.5B
Green Thumb Industries (GTBIF)$1.4B